Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges

Journal of Hepatology

Volumn 54, Issue 6, 2011, Pages 1286-1296

  Michel, Marie Louise ^a,b,c   Deng, Qiang ^d   Mancini Bourgine, Maryline ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Chronic infection; Clinical trial; DNA vaccine; Hepatitis B; Immunotherapy; T cell therapy; Vaccine

Indexed keywords

CLEVUDINE; DNA VACCINE; HEPATITIS B VACCINE; LAMIVUDINE; VIRUS VACCINE;

CELL THERAPY; CHRONIC HEPATITIS; CLINICAL TRIAL; HEPATITIS B; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION; VIRUS IMMUNITY; VIRUS LOAD;

EID: 79956071544     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.12.031     Document Type: Review

References (86)

1. D. Ganem, and A.M. Prince Hepatitis B virus infection - natural history and clinical consequences N Engl J Med 350 2004 1118 1129 (Pubitemid 38298992)
2. D.S. Chen Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B J Hepatol 50 2009 805 816
3. J.L. Dienstag Hepatitis B virus infection N Engl J Med 359 2008 1486 1500
4. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 2009 1593 1608 e1591-e1592
5. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 2005 215 229 (Pubitemid 40364823)
6. M.U. Mondelli, S. Varchetta, and B. Oliviero Natural killer cells in viral hepatitis: facts and controversies Eur J Clin Invest 40 2010 851 863
7. C. Dunn, D. Peppa, P. Khanna, G. Nebbia, M. Jones, and N. Brendish Temporal analysis of early immune responses in patients with acute hepatitis B virus infection Gastroenterology 137 2009 1289 1300
8. A. Bertoletti, and M.K. Maini Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 3 2000 387 392 (Pubitemid 30640363)
9. M. Isogawa, Y. Furuichi, and F.V. Chisari Oscillating CD8(+) T cell effector functions after antigen recognition in the liver Immunity 23 2005 53 63 (Pubitemid 41019657)
10. P. Fisicaro, C. Valdatta, C. Boni, M. Massari, C. Mori, and A. Zerbini Early kinetics of innate and adaptive immune responses during hepatitis B virus infection Gut 58 2009 974 982
11. B. Rehermann Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses Semin Liver Dis 27 2007 152 160 (Pubitemid 46871661)
12. M.K. Maini, and A. Schurich The molecular basis of the failed immune response in chronic HBV: therapeutic implications J Hepatol 52 2010 616 619
13. D.L. Barber, E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, and A.H. Sharpe Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 2006 682 687 (Pubitemid 43237609)
14. + T cell exhaustion during chronic viral infection Immunity 27 2007 670 684 (Pubitemid 47615511)
15. P. Fisicaro, C. Valdatta, M. Massari, E. Loggi, E. Biasini, and L. Sacchelli Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B Gastroenterology 138 2010 682 693 693,e681-e684
16. E.J. Wherry, D.L. Barber, S.M. Kaech, J.N. Blattman, and R. Ahmed Antigen-independent memory CD8 T cells do not develop during chronic viral infection Proc Natl Acad Sci USA 101 2004 16004 16009 (Pubitemid 39507917)
17. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy J Virol 78 2004 5707 5719 (Pubitemid 38661658)
18. A.R. Lopes, P. Kellam, A. Das, C. Dunn, A. Kwan, and J. Turner Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection J Clin Invest 118 2008 1835 1845 (Pubitemid 351632386)
19. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B J Immunol 177 2006 739 747 (Pubitemid 43939189)
20. J.N. Stoop, M.A. Claassen, A.M. Woltman, R.S. Binda, E.J. Kuipers, and H.L. Janssen Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients Clin Immunol 129 2008 419 427
21. J.N. Stoop, R.G. van der Molen, C.C. Baan, L.J. van der Laan, E.J. Kuipers, and J.G. Kusters Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 41 2005 771 778 (Pubitemid 40462939)
22. + regulatory T cells in patients with hepatitis B virus infection J Virol 79 2005 3322 3328 (Pubitemid 40327921)
23. A.M. Woltman, A. Boonstra, and H.L. Janssen Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels? Gut 59 2010 115 125
24. R.G. van der Molen, D. Sprengers, R.S. Binda, E.C. de Jong, H.G. Niesters, and J.G. Kusters Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B Hepatology 40 2004 738 746 (Pubitemid 39265597)
25. A. Untergasser, U. Zedler, A. Langenkamp, M. Hosel, M. Quasdorff, and K. Esser Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection Hepatology 43 2006 539 547
26. L. Chen, Z. Zhang, W. Chen, Y. Li, M. Shi, and J. Zhang B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B J Immunol 178 2007 6634 6641 (Pubitemid 46717448)
27. S. Pol, and M.L. Michel Therapeutic vaccination in chronic hepatitis B virus carriers Expert Rev Vaccines 5 2006 707 716 (Pubitemid 46021051)
28. A. Bertoletti, and A. Gehring Therapeutic vaccination and novel strategies to treat chronic HBV infection Expert Rev Gastroenterol Hepatol 3 2009 561 569
29. D.Z. Xu, K. Zhao, L.M. Guo, L.J. Li, Q. Xie, and H. Ren A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients PLoS One 3 2008 e2565
30. J.C. Aguilar, Y. Lobaina, V. Muzio, D. Garcia, E. Penton, and E. Iglesias Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen Immunol Cell Biol 82 2004 539 546 (Pubitemid 39421064)
31. A.A. Betancourt, C.A. Delgado, Z.C. Estevez, J.C. Martinez, G.V. Rios, and S.R. Aureoles-Rosello Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens Int J Infect Dis 11 2007 394 401 (Pubitemid 47239446)
32. S.M. Akbar, M. Al-Mahtab, S. Rahman, J.C. Aguilar, M. Onji, and S. Mishiro A therapeutic nasal vaccine combining both HBsAg and HBcAg wassafe, has antiviral potential and induced antigen-specific immunity in patients with chronic hepatitis B Hepatol Int 4 2010 159
33. C. Boni, A. Bertoletti, A. Penna, A. Cavalli, M. Pilli, and S. Urbani Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B J Clin Invest 102 1998 968 975 (Pubitemid 28419565)
34. C. Boni, A. Penna, A. Bertoletti, V. Lamonaca, I. Rapti, and G. Missale Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B J Hepatol 39 2003 595 605 (Pubitemid 37204661)
35. F. Le Guerhier, A. Thermet, S. Guerret, M. Chevallier, C. Jamard, and C.S. Gibbs Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model J Hepatol 38 2003 328 334 (Pubitemid 36286546)
36. S. Menne, C.A. Roneker, B.E. Korba, J.L. Gerin, B.C. Tennant, and P.J. Cote Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-l-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection J Virol 76 2002 5305 5314 (Pubitemid 34517881)
37. M. Roggendorf, D. Yang, and M. Lu The woodchuck: a model for therapeutic vaccination against hepadnaviral infection Pathol Biol (Paris) 58 2010 308 314
38. N. Leung Treatment of chronic hepatitis B: case selection and duration of therapy J Gastroenterol Hepatol 17 2002 409 414 (Pubitemid 34537291)
39. M. Al-Mahtab, S. Rahman, S.M. Akbar, S.I. Khan, H. Uddin, and F. Karim Combination therapy with antiviral drugs and hepatitis B vaccine in incidentally-detected and asymptomatic chronic hepatitis virus B carriers at Bangladesh Viral Immunol 23 2010 335 338
40. H. Senturk, F. Tabak, R. Ozaras, L. Erdem, B. Canbakan, and A. Mert Efficacy of pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection Dig Dis Sci 54 2009 2026 2030
41. P.T. Hoa, N.T. Huy, T. Thule, C.N. Nga, K. Nakao, and K. Eguchi Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B Antimicrob Agents Chemother 53 2009 5134 5140
42. P. Vandepapeliere, G.K. Lau, G. Leroux-Roels, Y. Horsmans, E. Gane, and T. Tawandee Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine Vaccine 25 2007 8585 8597 (Pubitemid 350192039)
43. N. Horiike, S.M. Fazle Akbar, K. Michitaka, K. Joukou, K. Yamamoto, and N. Kojima In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B J Clin Virol 32 2005 156 161 (Pubitemid 40093967)
44. C. Goujard, F. Marcellin, H. Hendel-Chavez, M. Burgard, V. Meiffredy, and A. Venet Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study AIDS Res Hum Retroviruses 23 2007 1105 1113 (Pubitemid 47571934)
45. A. Dahmen, S. Herzog-Hauff, W.O. Bocher, P.R. Galle, and H.F. Lohr Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B J Med Virol 66 2002 452 460
46. M. Pellegrini, T. Calzascia, A.R. Elford, A. Shahinian, A.E. Lin, and D. Dissanayake Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies Nat Med 15 2009 528 536
47. S.J. Ha, S.N. Mueller, E.J. Wherry, D.L. Barber, R.D. Aubert, and A.H. Sharpe Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection J Exp Med 205 2008 543 555 (Pubitemid 351439302)
48. T. Watanabe, A. Bertoletti, and T.A. Tanoto PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection J Viral Hepat 17 2010 453 458
49. M. Mancini, M. Hadchouel, H.L. Davis, R.G. Whalen, P. Tiollais, and M.L. Michel DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state Proc Natl Acad Sci USA 93 1996 12496 12501 (Pubitemid 26367172)
50. A.M. Prince, R. Whalen, and B. Brotman Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus Vaccine 15 1997 916 919 (Pubitemid 27287989)
51. D. Loirat, F.A. Lemonnier, and M.L. Michel Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization J Immunol 165 2000 4748 4755
52. J.J. Donnelly, B. Wahren, and M.A. Liu DNA vaccines: progress and challenges J Immunol 175 2005 633 639 (Pubitemid 41094942)
53. M. Mancini-Bourgine, H. Fontaine, D. Scott-Algara, S. Pol, C. Brechot, and M.L. Michel Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers Hepatology 40 2004 874 882 (Pubitemid 39288120)
54. D. Scott-Algara, M. Mancini-Bourgine, H. Fontaine, S. Pol, and M.L. Michel Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination PLoS One 5 2010 e8761
55. S.H. Yang, C.G. Lee, S.H. Park, S.J. Im, Y.M. Kim, and J.M. Son Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study Gene Ther 13 2006 1110 1117
56. E.I. Rigopoulou, D. Suri, S. Chokshi, I. Mullerova, S. Rice, and R.S. Tedder Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity Hepatology 42 2005 1028 1036 (Pubitemid 43112669)
57. S.J. Im, S.H. Yang, S.K. Yoon, and Y.C. Sung Increase of plasma IL-12/p40 ratio induced by the combined therapy of DNA vaccine and lamivudine correlates with sustained viremia control in CHB carriers Immune Netw 9 2009 20 26
58. S.C. Gilbert, V.S. Moorthy, L. Andrews, A.A. Pathan, S.J. McConkey, and J.M. Vuola Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis Vaccine 24 2006 4554 4561 (Pubitemid 43776762)
59. H. Ueno, N. Schmitt, E. Klechevsky, A. Pedroza-Gonzalez, T. Matsui, and G. Zurawski Harnessing human dendritic cell subsets for medicine Immunol Rev 234 2010 199 212
60. W. Lu, L.C. Arraes, W.T. Ferreira, and J.M. Andrieu Therapeutic dendritic-cell vaccine for chronic HIV-1 infection Nat Med 10 2004 1359 1365 (Pubitemid 40022718)
61. A.M. Leen, G.D. Myers, U. Sili, M.H. Huls, H. Weiss, and K.S. Leung Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals Nat Med 12 2006 1160 1166 (Pubitemid 44527351)
62. Akbar SM, Furukawa S, Horiike N, Abe M, Hiasa Y, Onji M. Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B. J Viral Hepat 2010. May 17 [Epub ahead of print].
63. S.M. Fazle Akbar, S. Furukawa, M. Onji, Y. Murata, T. Niya, and S. Kanno Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers Hepatol Res 29 2004 136 141 (Pubitemid 38780128)
64. J. Luo, J. Li, R.L. Chen, L. Nie, J. Huang, and Z.W. Liu Autologus dendritic cell vaccine for chronic hepatitis B carriers: a pilot, open label, clinical trial in human volunteers Vaccine 28 2010 2497 2504
65. A.T. Tan, E. Loggi, C. Boni, A. Chia, A.J. Gehring, and K.S. Sastry Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire J Virol 82 2008 10986 10997
66. Y. Ilan, A. Nagler, R. Adler, R. Tur-Kaspa, S. Slavin, and D. Shouval Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor Gastroenterology 104 1993 1818 1821 (Pubitemid 23235477)
67. C.K. Hui, A. Lie, W.Y. Au, Y.H. Leung, S.Y. Ma, and W.W. Cheung A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation Blood 106 2005 464 469 (Pubitemid 40981239)
68. M. Shi, J. Fu, F. Shi, B. Zhang, Z. Tang, and L. Jin Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection Clin Immunol 132 2009 43 54
69. B. Engels, and W. Uckert Redirecting T lymphocyte specificity by T cell receptor gene transfer-a new era for immunotherapy Mol Aspects Med 28 2007 115 142
70. A. Gehring, S.-A. Xue, Z.Z. Ho, D.Y.L. Teoh, C. Ruedl, and A. Chia Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines J Hepatol 2010 Nov 23 [Epub ahead of print]
71. F. Bohne, M. Chmielewski, G. Ebert, K. Wiegmann, T. Kurschner, and A. Schulze T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes Gastroenterology 134 2008 239 247 (Pubitemid 350309333)
72. Q. Deng, M. Mancini-Bourgine, X. Zhang, M.C. Cumont, R. Zhu, and Y.C. Lone Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models Hepatology 50 2009 1380 1391
73. P.L. Yang, A. Althage, J. Chung, and F.V. Chisari Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection Proc Natl Acad Sci USA 99 2002 13825 13830 (Pubitemid 35215465)
74. M. Mancini, M. Hadchouel, P. Tiollais, C. Pourcel, and M.L. Michel Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice. a possible way of circumventing " nonresponse" to HBsAg J Med Virol 39 1993 67 74 (Pubitemid 23030419)
75. S.M. Akbar, K. Kajino, K. Tanimoto, K. Kurose, T. Masumoto, and K. Michitaka Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice J Hepatol 26 1997 131 137 (Pubitemid 27072614)
76. E. Malanchere-Bres, P.J. Payette, M. Mancini, P. Tiollais, H.L. Davis, and M.L. Michel CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice J Virol 75 2001 6482 6491 (Pubitemid 32578167)
77. K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F.V. Chisari Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections J Virol 76 2002 8609 8620 (Pubitemid 34864055)
78. D. Loirat, M. Mancini-Bourgine, J.P. Abastado, and M.L. Michel HBsAg/HLA-A2 transgenic mice. a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection Int Immunol 15 2003 1125 1136 (Pubitemid 37220487)
79. R. Schirmbeck, N. Dikopoulos, M. Kwissa, F. Leithauser, K. Lamberth, and S. Buus Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants Eur J Immunol 33 2003 3342 3352 (Pubitemid 37541110)
80. M. Lu, G. Hilken, J. Kruppenbacher, T. Kemper, R. Schirmbeck, and J. Reimann Immunization of woodchucks with plasmids expressing Woodchuck Hepatitis Virus (WHV) core antigen and surface antigen suppresses WHV infection J Virol 73 1999 281 289 (Pubitemid 28565370)
81. C. Rollier, C. Sunyach, L. Barraud, N. Madani, C. Jamard, and C. Trepo Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein Gastroenterology 116 1999 658 665 (Pubitemid 29106774)
82. S. Pol, B. Nalpas, F. Driss, M.L. Michel, P. Tiollais, and J. Denis Efficacy and limitations of a specific immunotherapy in chronic hepatitis B J Hepatol 34 2001 917 921 (Pubitemid 32595193)
83. + T-cell proliferative response in chronic hepatitis B carriers Vaccine 20 2002 3598 3612 (Pubitemid 35248086)
84. X.Y. Wang, X. Yao, L.M. Guo, L.F. Xu, X.L. Shen, and D.Z. Xu Advances on antigen-antibody immunogenic complex therapeutic vaccine for viral hepatitis B Zhonghua Gan Zang Bing Za Zhi 17 2009 718 720
85. E. Depla, A. Van der Aa, B.D. Livingston, C. Crimi, K. Allosery, and V. De Brabandere Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections J Virol 82 2008 435 450 (Pubitemid 350309158)
86. A.V. Hill, A. Reyes-Sandoval, G. O'Hara, K. Ewer, A. Lawrie, and A. Goodman Prime-boost vectored malaria vaccines: progress and prospects Hum Vaccin 6 2010 78 83